PGC1α as a downstream effector of KDM5B promotes the progression of androgen receptor-positive and androgen receptor-negative prostate cancers
Yuki Teramoto(University of Rochester Medical Center)
Cited by 2
Related Papers
Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
|International Journal of Molecular Sciences|2021|21
Latrophilins as Downstream Effectors of Androgen Receptors including a Splice Variant, AR-V7, Induce Prostate Cancer Progression
|International Journal of Molecular Sciences|2024|4